Contact Us

All Categories

Refine Search

JH-XI-10-02

Novel potent and selective CDK8 degrader

JI-101

An oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4). JI-101 inhibits angiogenesis, and subsequently tumo..

JIB-04

Novel specific inhibitor of Jumonji demethylases

Jionoside A1

Polyphenols

Jionoside B1

Polyphenols

JMC-4

Novel 5-LOX inhibitor

JMS-053

Novel allosteric PTP4A3 inhibitor, increasing Emilin 1 gene expression

JMS-17-2

Novel potent and selective antagonist of CX3CR1

JNJ 63533054

Brain and cell penetrant, orally bioavailable, potent and selective GPR139 agonist.

JNJ-10181457 Dihydrochloride

Histamine H3 receptor antagonist

JNJ-17203212

Potent TRPV1 (VR1) vanilloid receptor antagonist

JNJ-26481585

Novel "second-generation" oral histone deacetylase inhibitor